PURE Bioscience Reports Second Quarter Results

March 19, 2012 |

1 min read

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (NASDAQ: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for its second quarter ended January 31, 2012.

Earnings

MORE ON THIS TOPIC

Illustration of employer’s hand holding employee who was laid off to drop him out of office

Layoffs

Sage Sacks Entire Staff After Supernus Buyout

June 30, 2025

·

1 min read

·

Tristan Manalac

Themis with sword and scales in cyberspace. Ai regulation, artificial intelligence and law issues concept. Vector illustration.

Legal

Supreme Court Leaves PrEP Drug Coverage Decisions to RFK’s Task Force

June 27, 2025

·

2 min read

·

Annalee Armstrong

Creative sketch collage of business people handshake gesture approval project development success colleagues cooperation support.

Collaboration

Alphabet Subsidiary Calico Colors In Up To $570M+ Aging Deal With China’s Mabwell

June 27, 2025

·

2 min read

·

Tristan Manalac

Successful businessman standing in front of multiple pathways, making a decision for the right move. A symbol of great investment and positive progress in the development of business. stock illustration

Mergers & acquisitions

Lilly-Verve Proxy Filing Reveals Tumult After Departure of FDA’s Marks

June 26, 2025

·

4 min read

·

Annalee Armstrong